| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $37.7M | +33.9% |
| SG&A Expense | $16.1M | +38.6% |
| Operating Income | -$53.8M | -35.2% |
| Pre-tax Income | -$52.0M | -30.6% |
| Income Tax | $0 | — |
| Net Income | -$52.0M | -30.6% |
| EPS (Basic) | -$2.12 | +3.2% |
| EPS (Diluted) | -$2.12 | +3.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.9M | -84.0% |
| Short-term Investments | $81.2M | +253.1% |
| Current Assets | $106.4M | -30.8% |
| Total Assets | $108.2M | -29.8% |
| Current Liabilities | $7.1M | +14.9% |
| Total Liabilities | $8.2M | +20.5% |
| Stockholders' Equity | $100.0M | -32.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.4M | -24.7% |
| Capital Expenditures | $346K | +74.7% |
| Investing Cash Flow | -$57.8M | -147.4% |
| Financing Cash Flow | $471K | -99.6% |
| Free Cash Flow | -$47.7M | -25.0% |